W. Middlekauff

W. Middlekauff

Keine laufenden Positionen mehr

Vermögen: 253 250 $ am 31.05.2026

65 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

W.
Bradford Middlekauff
is currently an Independent Director at Amanat Acquisition Corp.
since 2026 and Chief Business Officer & General Counsel at Tourmaline Sub, Inc. since 2022.
Former positions include Chairman at Biotechnology Innovation Organization, Director at SpliceBio SL, Senior Vice President-Strategic Planning at Medarex, Inc. from 2000 to 2008, VP-Business Development & General Counsel at Algos Pharmaceutical Corp.
from 1998 to 2000, Secretary, Chief Legal Officer & General Counsel at Kolltan Pharmaceuticals, Inc. from 2008 to 2013, Secretary, Senior Vice President & General Counsel at Edge Therapeutics, Inc., Associate at Cooley Godward LLP from 1993 to 1998, Secretary & Chief Legal Officer at PDS Biotechnology Corp.
in 2019, General Counsel at Immunovant, Inc. from 2019 to 2020, Chief Legal Officer at Castle Creek Biosciences, Inc. from 2021 to 2022, and Secretary & Chief Business Officer at Tourmaline Bio, Inc. from 2023 to 2025.
Education includes undergraduate studies at Brown University and graduate studies at Yale Law School.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
1,15 %
20.05.2026 25 000 ( 1,15 % ) 253 250 $ 31.05.2026

Aktive Positionen von W. Middlekauff

UnternehmenPositionBeginn
General Counsel 01.06.2022

Ehemalige bekannte Positionen von W. Middlekauff

UnternehmenPositionEnde
General Counsel 01.05.2022
IMMUNOVANT, INC. General Counsel 01.11.2020
PDS BIOTECHNOLOGY CORPORATION General Counsel 12.04.2019
General Counsel 01.08.2013
Sehen Sie sich die Erfahrung von W. Middlekauff im Detail an

Ausbildung von W. Middlekauff

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

57

Beziehungen ersten Grades

13

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen13

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Börse
  2. Insiders
  3. W. Middlekauff